2023
Immunity in the balance: Fatal disseminated adenovirus infection in a patient undergoing plasma exchange and immunosuppressive chemotherapy for anti‐glomerular basement membrane disease
Jacobs J, Villalba C, Stendahl K, Tormey C, Abels E. Immunity in the balance: Fatal disseminated adenovirus infection in a patient undergoing plasma exchange and immunosuppressive chemotherapy for anti‐glomerular basement membrane disease. Journal Of Clinical Apheresis 2023, 38: 770-777. PMID: 37698143, DOI: 10.1002/jca.22088.Peer-Reviewed Original ResearchConceptsTherapeutic plasma exchangeAnti-glomerular basement membrane diseaseAnti-GBM diseasePlasma exchangeMembrane diseaseDaily therapeutic plasma exchangeFatal disseminated adenovirus infectionRare autoinflammatory conditionsMulti-organ failureStandard therapeutic regimenDisseminated adenovirus infectionDisseminated adenovirus diseasePotential opportunistic infectionsPotential adverse effectsApheresis guidelinesAdenovirus diseaseOrgan inflammationProfound immunosuppressionAutoantibody productionOpportunistic infectionsTherapeutic regimenAutoinflammatory conditionsImmunosuppressive chemotherapyUnusual infectionsClose surveillance
2021
Anti‐glomerular basement membrane disease (Goodpasture disease): From pathogenesis to plasma exchange to IdeS
Shin J, Geetha D, Szpirt W, Windpessl M, Kronbichler A. Anti‐glomerular basement membrane disease (Goodpasture disease): From pathogenesis to plasma exchange to IdeS. Therapeutic Apheresis And Dialysis 2021, 26: 24-31. PMID: 34339589, DOI: 10.1111/1744-9987.13718.Peer-Reviewed Original ResearchConceptsAnti-GBM diseasePlasma exchangePoor prognosisCombination of therapeutic plasma exchangeGoodpasture's diseaseAnti-glomerular basement membrane diseaseAnti-glomerular basement membraneANCA-associated vasculitisPhase II trialStandard of care managementTherapeutic plasma exchangeBasement membrane diseaseLong-term treatmentAnti-GBM antibodiesSevere kidney failureSevere disease phenotypePrognostic factorsII trialMembrane diseasePulmonary hemorrhageEarly initiationRefine treatment approachesKidney failureTreatment approachesPatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply